Microbiome hypothesis
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Theory[edit | edit source]
Evidence[edit | edit source]
- 2015, Support for the Microgenderome: Associations in a Human Clinical Population (see also Sex Differences in CFS Microbiome)
- 2015, Prevotella copri and the microbial pathogenesis of rheumatoid arthritis (March)
- 2016, A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[1](Full Text)
- 2018, Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?[2] (Full Text)
- 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity[3] (Abstract)
See also[edit | edit source]
References[edit | edit source]
- ↑ Newberry, F.; Hsieh, S.-Y.; Wileman, T.; Carding, S.R. (2018), "Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?", Clinical Science, 132 (5): 523–542, doi:10.1042/CS20171330
- ↑ Proal, Amy; Marshall, Trevor (November 2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity". Frontiers in Pediatrics. doi:10.3389/fped.2018.00373.
